Donormil is a drug with sedative and hypnotic effects, used in the treatment of sleep disorders. The drug reduces the period of sleep, increases the duration of sleep, improves its quality, without changing the structure of sleep.
Release form and composition
Donormil comes in the form of coated tablets, in which the active ingredient is doxylamine succinate.
As excipients in tablets used: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose.
The shell includes: hypromellose, macrogol 6000, titanium dioxide CI 77891, water, propylene glycol.
Donormil tablets are available in polypropylene tubes, 30 pieces per pack.
Indications for use
According to the instructions, Donormil is used to treat transient sleep disorders.
According to the instructions, Donormil contraindicated for use with:
- The presence of a patient individual intolerance to the components of the drug;
- Angle-closure glaucoma;
- Congenital galactosemia, lactase deficiency, glucose-galactose malabsorption;
- Disorders of urine outflow against the background of diseases of the urethra and prostate gland;
as well as under the age of 15 years.
According to the instructions, Donormil carefully prescribed:
- If the patient has a history of apnea;
- Patients over 65;
- In renal and hepatic failure.
Dosing and Administration
Donormil tablets are intended for oral administration. They are taken on ½-1 piece for 15-30 minutes before bedtime, washed down with a small amount of liquid.
The dosage of the drug in the absence of a therapeutic effect can be increased by a doctor's prescription.
Duration of use Donormila - 2-5 days. If insomnia persists, consult a doctor.
Patients with renal or renal insufficiency, as well as the elderly (over 65 years), are required to reduce the dosage of the drug.
When using Donormil, the following adverse reactions may develop: dry mouth, constipation, palpitations, accommodation disturbances, daytime sleepiness, and urinary retention.
When applying Donormila should be borne in mind that:
- Insomnia can be caused by various reasons that do not require the prescription of this drug;
- The drug exacerbates the syndrome of sudden respiration in a dream, increases the number and duration of its attacks;
- It is not recommended to drive a car and other mechanisms while taking the drug because of possible drowsiness in the daytime;
- Overdose Donormilom manifests itself: daytime sleepiness, pupil dilation, agitation, redness of the face and neck, accommodation disturbances, fever, dry mouth, sinus tachycardia, hallucinations, disorders of consciousness, anxiety, deterioration of mood, impaired coordination of movements, involuntary movements, shivering cramps, coma. Convulsions, forerunners of which are involuntary movements, indicate a severe degree of drug poisoning. Overdose treatment is symptomatic;
- When the patient has daytime sleepiness, the dose should be reduced;
- The inhibitor ;
- The risk of constipation, urinary retention, dry mouth is increased when taking the drug simultaneously with imipramine antidepressants, atropine, antiparkinsonic drugs, disopyramide, atropine antispasmodics, phenothiazine neuroleptics;
- Donormila should be avoided simultaneously with alcohol-containing beverages and medications;
- Perhaps the use of the drug during the entire period of pregnancy. When taking Donormila in late pregnancy, when monitoring the condition of the newborn, it is necessary to take into account the sedative and atropine-like properties of the drug;
- During the period of breastfeeding, it is not recommended to take the drug because of the risk of developing an exciting or sedative effect in the child (there is no evidence that the drug penetrates into breast milk).
Structural analogues of Donormil are such drugs as Reslip, Doxylamine, Valocordin-Doxylamine.
Terms and conditions of storage
Donormil stored at a temperature of 15-25º in places with limited access of children no more than three years.
Donormil may not be used after the expiration date printed on the package.